Lord Abbett Securities Trust. Holdings as of Jul 31, 2026, from Form N-PORT.
Share of net assets at the report date, for the whole fund across all share classes.
| Holding | Weight | Value | Shares or units |
|---|---|---|---|
| Eli Lilly & CoLLY | 10.40% | $890.35K | 775 |
| UnitedHealth Group IncUNH | 5.39% | $462.06K | 1,115 |
| Novartis AG | 4.19% | $443.38K | 2,292 |
| Johnson & JohnsonJNJ | 4.96% | $424.52K | 1,656 |
| Natera IncNTRA | 3.60% | $308.19K | 1,151 |
| Gilead Sciences IncGILD | 3.53% | $302.48K | 2,323 |
| CVS Health CorpCVS | 3.33% | $285.51K | 2,734 |
| Galderma Group AG | 2.60% | $275.36K | 1,023 |
| AstraZeneca PLC | 1.97% | $227.43K | 992 |
| Guardant Health IncGH | 2.61% | $223.71K | 1,381 |
| Thermo Fisher Scientific IncTMO | 2.31% | $198.13K | 345 |
| Cogent Biosciences IncCOGT | 2.26% | $193.99K | 4,983 |
| Vertex Pharmaceuticals IncVRTX | 2.24% | $191.79K | 402 |
| 10X Genomics IncTXG | 2.16% | $184.83K | 3,910 |
| Ascendis Pharma A/S | 1.99% | $170.25K | 698 |
| Madrigal Pharmaceuticals IncMDGL | 1.91% | $163.56K | 350 |
| Bridgebio Pharma IncBBIO | 1.84% | $157.70K | 1,969 |
| Edwards Lifesciences CorpEW | 1.78% | $152.77K | 1,775 |
| Revolution Medicines IncRVMD | 1.67% | $143.27K | 764 |
| Argenx SE | 1.35% | $133.34K | 135 |
| UCB SA | 1.35% | $133.20K | 450 |
| Arrowhead Pharmaceuticals IncARWR | 1.52% | $130.19K | 1,538 |
| Protagonist Therapeutics IncPTGX | 1.44% | $123.66K | 905 |
| Dianthus Therapeutics IncDNTH | 1.44% | $123.17K | 1,152 |
| Adaptive Biotechnologies CorpADPT | 1.42% | $122.04K | 5,407 |
| Illumina IncILMN | 1.42% | $121.83K | 594 |
| United Therapeutics CorpUTHR | 1.41% | $121.14K | 234 |
| Mirum Pharmaceuticals IncMIRM | 1.34% | $115.17K | 1,087 |
| Glaukos CorpGKOS | 1.31% | $111.87K | 671 |
| PTC Therapeutics IncPTCT | 1.30% | $110.99K | 1,632 |
| Teva Pharmaceutical Industries Ltd | 1.21% | $103.52K | 2,957 |
| Fixed Income Clearing Corp.RA | 1.21% | $103.31K | 103,313 |
| Intuitive Surgical IncISRG | 1.07% | $91.51K | 259 |
| Roivant Sciences Ltd | 1.06% | $90.68K | 2,674 |
| CG oncology IncCGON | 1.02% | $87.07K | 1,223 |
| Hinge Health IncHNGE | 0.98% | $83.90K | 1,123 |
| Enliven Therapeutics IncELVN | 0.95% | $81.01K | 1,478 |
| Oruka Therapeutics IncORKA | 0.93% | $79.91K | 828 |
| Celcuity IncCELC | 0.90% | $77.40K | 896 |
| Encompass Health CorpEHC | 0.88% | $75.19K | 677 |
| West Pharmaceutical Services IncWST | 0.81% | $69.56K | 204 |
| Newamsterdam Pharma Co NV | 0.81% | $69.36K | 2,496 |
| Forte Biosciences Inc | 0.79% | $67.48K | 881 |
| Definium Therapeutics IncDFTX | 0.74% | $63.50K | 1,459 |
| Alumis IncALMS | 0.72% | $61.67K | 2,183 |
| Stryker CorpSYK | 0.71% | $60.58K | 186 |
| Praxis Precision Medicines IncPRAX | 0.69% | $59.41K | 193 |
| Fidelity InvestmentsCash or money market | 0.68% | $58.35K | 58,347 |
| Tango Therapeutics IncTNGX | 0.63% | $54.36K | 2,000 |
| IDEXX Laboratories IncIDXX | 0.58% | $49.76K | 89 |